morning all
I had Her2+++ breast cancer and have about a 20% risk of recurrence according to the predict tool
http://www.predict.nhs.uk/predict_v2.0.html
If I had private healthcare I'd have a selection of drugs to keep me going, Herceptin, Perjeta, Kadcyla.
On the NHS I can have Herceptin and Perjeta but Perjeta is possibly about to be rejected.
insert gold standard care for primary Her2+ breast cancer :
I had EC x 4 and T x 4 and Herceptin x 18
for metastatic or advanced : as I understand it you stay on one until it stops working and move on to the next.
but I'll build a better picture as I research it more and you guys all chip in
this is our group now so bookmark it. we can't have an actual group but this will work.
I'll tag a few people, as I remember who is Her2+ toxophilite is first since you messaged me, ... who else ? Kacang ? although you have the luxury of a slightly different system down under.
| jowoomot
welcome to the gang
Carolyn
xx
AND ...
we did it
http://breastcancernow.org/news-and-blogs/news/lifeline-drug-kadcyla-approved-for-routine-use-on-nhs
NHS England and The National Institute for Health and Care Excellence (NICE) has today announced that secondary breast cancer drug trastuzumab emtansine (Kadcyla, Roche Products) is to be made available for routine use on the NHS, in new (final) guidance following its reappraisal.
yay
xxx
Carolyn
real life success stories to remind you that people do survive breast cancer
https://community.macmillan.org.uk/cancer_types/breast-cancer/f/38/t/115457
Dr Peter Harvey
https://www.workingwithcancer.co.uk/wp-content/uploads/2013/03/After-the-treatment-finishes-then-what.pdf
